Correction to “Flow cytometry to detect bone marrow involvement by follicular lymphoma”

IF 2.3 3区医学 Q3 MEDICAL LABORATORY TECHNOLOGY

Cytometry Part B: Clinical Cytometry Pub Date : 2023-03-16 DOI:10.1002/cyto.b.22111

引用次数: 1

Abstract

Aren, M., Marce, S., Jurado, R., Tapia, G., Puigdefabregues, L., Raya, M., Cortes, M., Garcia-Caro, M., Junca, J., Mozas, P., Viñets, E., Cabezon, M., Plensa, E., Miljkovic, M., Sancho, J.-M., Navarro, J.-T., Zamora, L., & Sorigue, M. (2022). Flow cytometry to detect bone marrow involvement by follicular lymphoma. Cytometry Part B: Clinical Cytometry, 102(6), 427–439. https://doi.org/10.1002/cyto.b.22098

Coauthor Esther Plensa's affiliation was incorrectly given as Department of Hematology, ICO-Mataro, Badalona, Spain. The correct affiliation is Department of Hematology and Hemotherapy, Consorci Sanitari del Maresme, Hospital de Mataró, Institut Català d'Oncologia, Mataró, Spain.

We apologize for this error.

查看原文本刊更多论文

对“流式细胞术检测滤泡性淋巴瘤累及骨髓”的修正

Aren，M.，Marce，S.，Jurado，R.，Tapia，G.，Puigdefabregues，L.，Raya，M.，Cortes，M.，Garcia Caro，M.，Junca，J.，Mozas，P.，Viñets，E.，Cabezon，M.，Plensa，E.，Miljkovic，M.，Sancho，J.-M，Navarro，J.-T，Zamora，L；Sorigue，M.（2022）。流式细胞术检测滤泡性淋巴瘤累及骨髓。细胞测定学第B部分：临床细胞测定学，102（6），427–439。https://doi.org/10.1002/cyto.b.22098CoauthorEsther Plensa的隶属关系被错误地指定为西班牙巴达洛纳ICO Mataro血液科。正确的附属机构是西班牙马塔罗Catalàd‘Oncologia研究所马塔罗医院血液和血液治疗科。我们对此错误深表歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cytometry Part B: Clinical Cytometry 医学-病理学

CiteScore

6.80

自引率

32.40%

发文量

审稿时长

>12 weeks

期刊介绍： Cytometry Part B: Clinical Cytometry features original research reports, in-depth reviews and special issues that directly relate to and palpably impact clinical flow, mass and image-based cytometry. These may include clinical and translational investigations important in the diagnostic, prognostic and therapeutic management of patients. Thus, we welcome research papers from various disciplines related [but not limited to] hematopathologists, hematologists, immunologists and cell biologists with clinically relevant and innovative studies investigating individual-cell analytics and/or separations. In addition to the types of papers indicated above, we also welcome Letters to the Editor, describing case reports or important medical or technical topics relevant to our readership without the length and depth of a full original report.